(MENAFN- AFP) The US market regulator is examining Japanese mobile giant SoftBank over misconduct allegations lodged against its former president Nikesh Arora, who quit last week, a report said Thursday.
The Securities and Exchange Commission (SEC) is seeking to find out whether Arora had conflicts of interest or engaged in questionable behaviour, Bloomberg News reported, citing unnamed people familiar with the matter.
The watchdog was also eyeing SoftBank's disclosures to investors, it said, adding that the inquiry was a preliminary step and does not guarantee further action against the company or its former executive.
"SoftBank Group does not comment on press reports of (US) regulatory inquiries," the company said in a statement on Thursday in response to the report.
India-born Arora, once seen as SoftBank boss Masayoshi Son's heir apparent, stepped down last week just two years after being plucked from a high-profile job at Google.
Son told an annual shareholders meeting he had changed his mind about the timeline for stepping down to make way for right-hand man Arora.
Both men said it was an amicable split, and Arora would stay on as SoftBank advisor.
But his resignation came as SoftBank said an independent group of board members had cleared Arora of misconduct allegations lodged by an investor group.
The shareholders were calling for Arora's ouster over potential conflicts of interest tied to his role as an adviser to a private equity firm.
"The special committee concluded that (the) claims were without merit," the company statement said, referring to the independent group of board members.
SoftBank's Tokyo-listed shares were down 1.02 percent at 5,749 yen ($56) at midday.
Legal Disclaimer:
MENAFN provides the information “as is” without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the provider above.